Search
Thursday 15 October 2015
  • :
  • :

(QTM) (ITW) (AERI) (DISH) Active News Update: Quantum (NYSE:QTM), Illinois Tool Works (NYSE:ITW), Aerie Pharmaceuticals (NASDAQ:AERI), DISH Network Corp (NASDAQ:DISH)

On Thursday, Quantum Corp (NYSE:QTM)’s shares inclined 11.87% to $0.780.

Quantum Corp. (QTM) declared the appointment of Bassam Tabbara as chief technology officer, with responsibility for driving the company’s long-term technology strategy as it builds on its leadership in scale-out storage, archive and data protection. Tabbara has more than 20 years of experience in planned product development — identifying and delivering on new innovation opportunities. He joined Quantum in August 2014 as part of its acquisition of Symform’s cloud platform, having served as the company’s CTO and co-founder.

Since joining Quantum, Tabbara has played a key role in defining the company’s cloud technology direction and in the development of its new Q-Cloud™ service offerings. These offerings enable customers to integrate the public cloud seamlessly into a multitier storage architecture that provides a unique combination of high performance and low cost.

At Symform, Tabbara built a revolutionary cloud storage platform from the ground up, ultimately storing billions of objects for users and small businesses across 170 countries. Before that, he spent 12 years at Microsoft in key leadership roles where he worked on a number of key initiatives, counting Microsoft Research, MSN, Windows, Visual Studio and System Center. Tabbara also holds more than 30 patents.

Quantum Corporation provides scale-out storage, archive, and data protection solutions for small businesses to major enterprises in the Americas, Europe, and the Asia Pacific. Its scale-out storage portfolio comprises StorNext software, appliances and full systems called StorNext Pro Solutions, in addition to Lattus extended online storage and Q-Cloud Archive services.

Illinois Tool Works Inc. (NYSE:ITW)’s shares dropped -0.92% to $81.55.

Illinois Tool Operates Inc. (ITW) declared that it will hold its 2015 third quarter conference call on Wednesday, October 21, 2015. The conference call will start at 9 a.m. central time and will follow the Company’s release of first quarter financial results at 7 a.m. central time on that same day.

Illinois Tool Operates Inc. manufactures and sells industrial products and equipment worldwide. It operates through seven segments: Automotive OEM; Test & Measurement and Electronics; Food Equipment; Polymers & Fluids; Welding; Construction Products; and Specialty Products. The Automotive OEM segment produces components and fasteners for automotive-related applications.

At the end of Thursday’s trade, Aerie Pharmaceuticals Inc (NASDAQ:AERI)‘s shares surged 4.11% to $18.47.

Aerie Pharmaceuticals, Inc. (AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, recently stated the successful results of its second Phase 3 trial for Rhopressa™, a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

Rhopressa™ Phase 3 Highlights for Rocket 2

  • Rhopressa™, dosed both once-daily and twice-daily, achieved its primary efficacy endpoint demonstrating non-inferiority contrast to twice-daily timolol. The primary efficacy endpoint evaluated subjects with pre-study baseline IOPs of above 20 to below 25 mmHg (millimeters of mercury).
  • The Rocket 2 efficacy results for Rhopressa™ demonstrated a compriseent level of IOP lowering across all baseline IOPs and throughout the 90-day efficacy period.
  • The most common Rhopressa™ adverse event was hyperemia, or eye redness, which was stated as raised in 35 percent of patients and was scored as mild for 83 percent of patients in the Rhopressa™ once-daily arm of the trial. The adverse event profile for the Rhopressa™once-daily arm was compriseent with the results of Rocket.

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases.

DISH Network Corp (NASDAQ:DISH), ended its Thursday’s trading session with 0.79% gain, and closed at $58.80.

DISH has partnered with Common Sense Media, the nation’s leading nonprofit organization dedicated to assisting kids and families thrive in a world of media and technology. The integration of Common Sense Media to the DISH Anywhere platform will provide households with age-appropriate ratings and reviews, in addition to content ratings that evaluate on a 0–5 scale the degree to which certain topics, counting violence, positive role models, sex, and language, are present in a movie or TV show.

Ratings and Reviews

Customers using DISHAnywhere.com now can access independently conducted age-based ratings and reviews for thousands of titles.

Common Sense Media provides a minimum age rating for each title, up to 18 years. Age ratings are followed by a brief overview of what parents should know before their families view a TV series or movie, counting a short analysis of how young viewers may react to various aspects of a title’s plot and theme.

DISH Network Corporation, through its auxiliaries, provides pay TV services in the United States. The company operates through two segments, DISH and Wireless. The company provides video services under the DISH brand.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *